Yaxin Wang, PhD (seated left), O.H. Frazier, MD (seated right) will collaborate with researchers at Georgia Tech, North Carolina State University and Rice University to develop a novel LVAD as an alternative treatment option to cardiac transplantation and long-term support in end-stage heart failure.